Effects of pioglitazone on proliferation,apoptosis and function of endothelial progenitor cells
DI Chun-Xia,LU Qing-Ming,GUO Wen-Yi,WANG Hai-Chang,ZHANG Rong-Qing,YIN Zhong
DOI: https://doi.org/10.3321/j.issn:1000-2790.2008.11.007
2008-01-01
Abstract:AIM: To investigate the effects of different doses of pioglitazone on the proliferation, apoptosis and function of endothelial progenitor cells (EPCs) derived from bone marrow. METHODS: Twenty-four SD rats were devided into 4 groups randomly. The rats in group A (control group) received normal saline by intragastric administration, the rats in group B, C and D received pioglitazone 10, 20, 40 mg/(kg·d) respectively for 10 d. Mononuclear cells were collected from rats' bone marrow by density gradient centrifugation, cultured with Medium 199, and were identified by UEA-I and ac-LDL staining, and the double positive ones were identified as EPCs. Once being harvested, EPCs of each group were calculated and cultured. After 24 h of incubation, NO secretion of EPCs was measured by the Griess assay with spectrophotometer. Being incubated for 3 d, apoptosis rate was detected by FCM. After 7 d of incubation, proliferation capacity was measured by MTT assay. RESULTS: Compared with group A, proliferation of EPCs increased[A490 nm: (0.423±0.004), (0.680±0.008), (0.443±0.005) vs control (0.143±0.006), P<0.05], the apoptosis rate decreased [(32.8±0.8)%, (30.9±2.3)%, (33.0±3.9)% vs control (40.1±1.1)%, P<0.05] and the production of NO enhanced [μmol/L, (29.2±3.7), (41.0±7.7), (28.7±6.4) vs control (18.9±1.4), P<0.05] in the group B, C and D. Group C showed the strongest effects among the 3 pioglitazone groups. CONCLUSION: Pioglitazone can improve the proliferation and the function of EPCs. The medium dose of 20 mg/(kg·d) of pioglitazone has better effects.